LANGER ROBERT
Insider CIK 1239757 · ACTC Director · NVIV 10% owner · LYRA Director · BIND Director · KALA Director, 10% owner · MRNA Director · FREQ Director · RUBY Director · SEER Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SEER Seer, Inc. | A Award deriv | 2026-07-28 | 2026-07-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SEER Seer, Inc. | A Award | 2026-07-28 | 2026-07-30 | 16,500 | — | $0 | 821,025 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2026-07-28 | 2026-07-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SEER Seer, Inc. | A Award | 2026-07-28 | 2026-07-30 | 16,500 | — | $0 | 821,025 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2025-07-07 | 2025-07-09 | 30,500 | — | $0 | 30,500 | SEC↗ |
| SEER Seer, Inc. | A Award | 2025-07-07 | 2025-07-09 | 20,500 | — | $0 | 804,525 | SEC↗ |
| SEER Seer, Inc. | A Award | 2024-06-12 | 2024-06-14 | 58,178 | — | $0 | 784,025 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2024-05-06 | 2024-05-07 | 7,557 | — | $0 | 7,557 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 34,735 | — | $0 | 34,735 | SEC↗ |
| SEER Seer, Inc. | A Award | 2023-06-14 | 2023-06-16 | 23,443 | — | $0 | 725,847 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 6,134 | — | $0 | 6,134 | SEC↗ |
| FREQ Frequency Therapeutics, In | D To issuer deriv | 2022-08-17 | 2022-08-19 | 14,846 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2022-08-17 | 2022-08-19 | 14,846 | — | $0 | 14,846 | SEC↗ |
| FREQ Frequency Therapeutics, In | D To issuer deriv | 2022-08-17 | 2022-08-19 | 14,846 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2022-08-17 | 2022-08-19 | 14,846 | — | $0 | 14,846 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2022-06-21 | 2022-06-23 | 14,846 | — | $0 | 14,846 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 29,640 | — | $0 | 29,640 | SEC↗ |
| SEER Seer, Inc. | A Award | 2022-06-15 | 2022-06-17 | 9,945 | — | $0 | 702,404 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise deriv | 2022-04-28 | 2022-05-02 | 703 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2022-04-28 | 2022-05-02 | 5,415 | — | $0 | 5,415 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise | 2022-04-28 | 2022-05-02 | 703 | — | $0 | 11,467,664 | SEC↗ |
| SEER Seer, Inc. | C Conversion deriv | 2022-01-10 | 2022-01-12 | 327,102 | — | $0 | 0 | SEC↗ |
| SEER Seer, Inc. | C Conversion | 2022-01-10 | 2022-01-12 | 327,102 | — | $0 | 692,459 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2021-06-17 | 2021-06-21 | 14,846 | — | $0 | 14,846 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2021-04-28 | 2021-04-30 | 703 | — | $0 | 703 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2021-04-28 | 2021-04-30 | 4,081 | — | $0 | 4,081 | SEC↗ |
| SEER Seer, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-09 | 205,831 | — | $0 | 0 | SEC↗ |
| SEER Seer, Inc. | C Conversion | 2020-12-08 | 2020-12-09 | 205,831 | — | $0 | 365,357 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2020-12-03 | 2020-12-11 | 18,691 | — | $0 | 18,691 | SEC↗ |
| FREQ Frequency Therapeutics, In | G Gift | 2020-11-17 | 2020-11-19 | 56,912 | — | $0 | 214,326 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2020-06-11 | 2020-06-12 | 14,846 | — | $0 | 14,846 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 23,057 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion | 2020-05-05 | 2020-05-06 | 668 | — | $0 | 15,167 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2020-04-30 | 2020-05-01 | 14,500 | — | $0 | 14,500 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2020-04-29 | 2020-04-30 | 18,270 | — | $0 | 18,270 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2019-10-14 | 2019-10-17 | 7,500 | — | $0 | 120,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2019-10-14 | 2019-10-17 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2019-10-14 | 2019-10-17 | 7,500 | $8.52 | $63.9K | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2019-07-15 | 2019-07-17 | 7,500 | — | $0 | 127,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2019-07-15 | 2019-07-17 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2019-07-15 | 2019-07-17 | 7,500 | $14.94 | $112.0K | 0 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2019-06-27 | 2019-06-28 | 54,660 | — | $0 | 54,660 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2019-05-23 | 2019-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2019-04-15 | 2019-04-17 | 7,500 | — | $0 | 135,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2019-04-15 | 2019-04-17 | 7,500 | $17.57 | $131.8K | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2019-04-15 | 2019-04-17 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2019-01-14 | 2019-01-18 | 7,500 | — | $0 | 142,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2019-01-14 | 2019-01-18 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2019-01-14 | 2019-01-18 | 7,500 | $14.59 | $109.4K | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 4,559 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 4,559 | — | $0 | 11,466,961 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-06-12 | 2018-06-15 | 12,960 | — | $0 | 12,960 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-07-19 | 2017-07-21 | 12,960 | — | $0 | 12,960 | SEC↗ |
| BIND DNIB UNWIND, INC. | M Exercise deriv | 2016-08-26 | 2016-08-30 | 15,000 | — | $0 | 0 | SEC↗ |
| BIND DNIB UNWIND, INC. | M Exercise | 2016-08-26 | 2016-08-30 | 15,000 | $0.44 | $6.6K | 738,424 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2016-06-21 | 2016-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 1,250 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 20,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | U Tender | 2016-02-10 | 2016-02-11 | 51,000 | $8.50 | $433.5K | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award deriv | 2016-01-04 | 2016-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-12-31 | 2016-01-04 | 1,250 | — | $0 | 52,250 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-09-30 | 2015-10-01 | 1,250 | — | $0 | 51,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-06-30 | 2015-07-02 | 1,250 | — | $0 | 49,750 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-03-31 | 2015-04-01 | 1,250 | — | $0 | 48,500 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award deriv | 2015-01-02 | 2015-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2014-12-31 | 2015-01-02 | 1,250 | — | $0 | 47,250 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2014-09-30 | 2014-10-01 | 1,250 | — | $0 | 46,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2014-06-30 | 2014-07-02 | 125,000 | — | $0 | 4,475,000 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2014-05-28 | 2014-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2014-03-31 | 2014-04-02 | 125,000 | — | $0 | 4,350,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-01-02 | 2014-01-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-12-31 | 2014-01-03 | 125,000 | — | $0 | 4,225,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-09-30 | 2013-10-02 | 125,000 | — | $0 | 4,100,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-06-28 | 2013-07-01 | 125,000 | — | $0 | 3,975,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-06-05 | 2013-06-05 | 2,500 | $3.91 | $9.8K | 7,433,628 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-06-04 | 2013-06-05 | 2,500 | $3.90 | $9.8K | 7,436,128 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-06-03 | 2013-06-05 | 2,500 | $3.37 | $8.4K | 7,436,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-31 | 2013-05-31 | 2,500 | $3.39 | $8.5K | 7,438,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-30 | 2013-05-31 | 2,500 | $3.40 | $8.5K | 7,441,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-29 | 2013-05-31 | 2,500 | $3.13 | $7.8K | 7,443,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-28 | 2013-05-28 | 2,500 | $3.03 | $7.6K | 7,446,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-24 | 2013-05-28 | 2,500 | $2.97 | $7.4K | 7,448,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-23 | 2013-05-28 | 2,500 | $2.90 | $7.3K | 7,451,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-22 | 2013-05-22 | 2,500 | $2.89 | $7.2K | 7,453,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-21 | 2013-05-22 | 2,500 | $2.87 | $7.2K | 7,456,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-20 | 2013-05-22 | 2,500 | $2.88 | $7.2K | 7,458,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-17 | 2013-05-17 | 2,500 | $2.86 | $7.2K | 7,461,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-16 | 2013-05-17 | 2,500 | $2.84 | $7.1K | 7,463,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-15 | 2013-05-17 | 2,500 | $2.85 | $7.1K | 7,466,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-14 | 2013-05-14 | 2,500 | $2.85 | $7.1K | 7,468,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-13 | 2013-05-14 | 2,500 | $3.00 | $7.5K | 7,471,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-10 | 2013-05-14 | 2,500 | $2.89 | $7.2K | 7,473,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-09 | 2013-05-09 | 2,500 | $2.94 | $7.3K | 7,476,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-08 | 2013-05-09 | 2,500 | $2.86 | $7.2K | 7,478,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-07 | 2013-05-09 | 2,500 | $2.94 | $7.3K | 7,481,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-06 | 2013-05-06 | 2,500 | $3.00 | $7.5K | 7,483,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-03 | 2013-05-06 | 2,500 | $3.02 | $7.5K | 7,486,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-02 | 2013-05-06 | 2,500 | $3.05 | $7.6K | 7,488,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-05-01 | 2013-05-01 | 2,500 | $3.17 | $7.9K | 7,491,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-04-30 | 2013-05-01 | 2,500 | $3.19 | $8.0K | 7,493,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-04-29 | 2013-05-01 | 2,500 | $2.99 | $7.5K | 7,496,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-04-26 | 2013-04-26 | 2,500 | $2.85 | $7.1K | 7,498,878 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-04-25 | 2013-04-26 | 2,500 | $2.94 | $7.3K | 7,501,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-04-24 | 2013-04-26 | 2,500 | $2.96 | $7.4K | 7,503,878 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-03-28 | 2013-04-01 | 125,000 | — | $0 | 3,850,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-01-17 | 2013-01-17 | 52,425 | $2.46 | $129.0K | 7,506,378 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-01-16 | 2013-01-17 | 102,874 | $2.46 | $253.1K | 7,558,803 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2013-01-15 | 2013-01-17 | 35,436 | $2.47 | $87.5K | 7,661,677 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2013-01-02 | 2013-02-26 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-12-31 | 2013-01-04 | 125,000 | — | $0 | 3,725,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-09-28 | 2012-10-03 | 125,000 | — | $0 | 3,600,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2012-07-02 | 2012-07-02 | 20,220 | $2.39 | $48.3K | 7,697,113 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2012-06-29 | 2012-07-02 | 24,780 | $2.31 | $57.2K | 7,717,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-06-29 | 2012-07-10 | 125,000 | — | $0 | 3,475,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2012-06-28 | 2012-06-28 | 15,000 | $2.30 | $34.5K | 7,742,113 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2012-06-27 | 2012-06-28 | 13,450 | $2.40 | $32.3K | 7,757,113 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2012-06-26 | 2012-06-28 | 126,550 | $2.42 | $306.3K | 7,770,563 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2012-04-16 | 2012-04-17 | 159,840 | $2.40 | $383.6K | 7,897,113 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2012-04-13 | 2012-04-17 | 40,160 | $2.39 | $96.0K | 8,056,953 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-03-30 | 2012-04-03 | 125,000 | — | $0 | 3,350,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2012-01-03 | 2012-08-09 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | S Sale | 2011-12-29 | 2012-01-03 | 165,247 | $2.49 | $411.5K | 8,097,113 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2011-10-04 | 2012-02-24 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2011-10-04 | 2012-02-24 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2011-10-04 | 2012-02-24 | 3,000,000 | — | $0 | 3,225,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2011-10-04 | 2012-02-24 | 225,000 | — | $0 | 225,000 | SEC↗ |